NCT05057130 2024-04-01
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
Phase 2/3 Recruiting
Clinical Trials
4 trialsNCT02856048 2019-12-17
PRESOV
Assistance Publique - Hôpitaux de Paris
Phase 2/3 Unknown
NCT02711007 2018-04-23
Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy
Peking University People's Hospital
Phase 2/3 Completed
NCT00691236 2011-06-23
ZOL
Tata Memorial Hospital
Phase 2/3 Unknown